Triple therapy for age-related macular degeneration

Retina

Volumn 29, Issue SUPPL. 6, 2009, Pages

  Augustin, Albert ^a,b  

^a Klinikum Karlsruhe   (Germany)

^b Augenklinik   (Germany)

Author keywords

Choroidal neovascularization; Combination therapy; Wet age related macular degeneration

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE;

CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NOTE; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; STEROID THERAPY; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; COMBINED MODALITY THERAPY; DEXAMETHASONE; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 68049127818     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181ad253d     Document Type: Note

References (4)

1. Schmidt-Erfurth U, Scholtzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GOH. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2001;44:4473-4480.
2. Tatar O, Shinoda K, Kaiserling E, et al. Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization. Arch Ophthalmol 2008;126:193-199. (Pubitemid 351246678)
3. Liggett PE, Colina J, Chaudry NA, Tom D, Haffner G. Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization. Am J Ophthalmol 2006;142:1072-1074. (Pubitemid 44853900)
4. Augustin AJ, Puls S, Offermann I. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone. Retina 2007;27:133-140. (Pubitemid 46245638)